NF2 Gene

HGNC Family A-kinase anchor proteins (AKAP)
Name neurofibromin 2 (merlin)
Description This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein's function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe neurofibromatosis 2 (NF2) gene product, Merlin, functions as a critical tumor suppressor by integrating extracellular cues with intracellular signaling cascades. In many cell types Merlin adopts a “closed” conformation that permits its nuclear relocation, where it directly binds and inhibits the CRL4(DCAF1) E3 ubiquitin ligase. This nuclear activity suppresses oncogenic transcriptional programs—most notably by maintaining proper Hippo pathway activity and restraining the nuclear accumulation and transcriptional activity of effectors like YAP. Merlin’s function is further fine‐tuned by reversible phosphorylation events: kinases (such as PKA and PAK) phosphorylate Merlin at key residues, while phosphatases like MYPT‑1–PP1δ dephosphorylate it, thus modulating its growth‑inhibitory capacity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn parallel to its nuclear roles, Merlin orchestrates a host of cell–intrinsic signaling pathways at the plasma membrane that are essential for maintaining proper cell–cell adhesion and controlled motility. Through interactions with proteins such as Angiomotin and Rich1, Merlin dampens Rac1 and Ras–MAPK signaling and helps regulate receptor trafficking and tight‐junction assembly. Moreover, loss of Merlin function—whether by inactivating mutations or misregulation through aberrant phosphorylation—leads to heightened integrin/FAK and mTORC1 signaling. These changes contribute to abnormal cell proliferation, altered collective migration, and increased sensitivity to targeted inhibitors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic and genomic analyses have underscored the broad clinical significance of NF2 inactivation across multiple tumor types. NF2 alterations—not only point mutations and large deletions but also epigenetic changes such as promoter methylation—are recurrent in meningiomas, schwannomas, malignant mesotheliomas, renal cell carcinomas, and other cancers. In many of these contexts, NF2 loss fosters aberrant Hippo, RAS, and even innate immune signaling, thereby promoting tumor progression and influencing therapeutic responsiveness. Consequently, NF2 status now shows promise not only as a prognostic biomarker but also as a predictor of sensitivity to agents targeting pathways such as FAK, mTOR, or ferroptosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kaija Alfthan, Leena Heiska, Mikaela Grönholm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M313916200"}], "href": "https://doi.org/10.1074/jbc.M313916200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14981079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14981079"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Rong Rong, Ezequiel I Surace, Carrie A Haipek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1207794"}], "href": "https://doi.org/10.1038/sj.onc.1207794"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15378014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15378014"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Guang-Hui Xiao, Ryan Gallagher, Justin Shetler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.25.6.2384-2394.2005"}], "href": "https://doi.org/10.1128/MCB.25.6.2384-2394.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15743831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15743831"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hongchuan Jin, Tobias Sperka, Peter Herrlich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature04856"}], "href": "https://doi.org/10.1038/nature04856"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16885985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16885985"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wei Li, Liru You, Jonathan Cooper, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2010.01.029"}], "href": "https://doi.org/10.1016/j.cell.2010.01.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20178741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20178741"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ivan Stamenkovic, Qin Yu "}, {"type": "b", "children": [{"type": "t", "text": "Merlin, a \"magic\" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Protein Pept Sci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/138920310791824011"}], "href": "https://doi.org/10.2174/138920310791824011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20491622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20491622"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Youjun Li, Hao Zhou, Fengzhi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cr.2015.69"}], "href": "https://doi.org/10.1038/cr.2015.69"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26045165"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26045165"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Marianne F James, Sangyeul Han, Carolyn Polizzano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01581-08"}], "href": "https://doi.org/10.1128/MCB.01581-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19451225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19451225"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Miguel A López-Lago, Tomoyo Okada, Miguel M Murillo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01578-08"}], "href": "https://doi.org/10.1128/MCB.01578-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19451229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19451229"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chunling Yi, Scott Troutman, Daniela Fera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2011.02.017"}], "href": "https://doi.org/10.1016/j.ccr.2011.02.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21481793"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21481793"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Isabel Serrano, Paul C McDonald, Frances Lock, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms3976"}], "href": "https://doi.org/10.1038/ncomms3976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24356468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24356468"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jonathan Cooper, Filippo G Giancotti "}, {"type": "b", "children": [{"type": "t", "text": "Molecular insights into NF2/Merlin tumor suppressor function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2014.04.001"}], "href": "https://doi.org/10.1016/j.febslet.2014.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24726726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24726726"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Irina M Shapiro, Vihren N Kolev, Christian M Vidal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.3008639"}], "href": "https://doi.org/10.1126/scitranslmed.3008639"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24848258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24848258"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Wei Li, Jonathan Cooper, Lu Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2014.05.001"}], "href": "https://doi.org/10.1016/j.ccr.2014.05.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25026211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25026211"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Tamal Das, Kai Safferling, Sebastian Rausch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A molecular mechanotransduction pathway regulates collective migration of epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb3115"}], "href": "https://doi.org/10.1038/ncb3115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25706233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25706233"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Michael E Baser, Lisa Kuramoto, Harry Joe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/422700"}], "href": "https://doi.org/10.1086/422700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15190457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15190457"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jesus Lomas, M Josefa Bello, Dolores Arjona, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20141"}], "href": "https://doi.org/10.1002/gcc.20141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15609345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15609345"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Siegal Sadetzki, Pazit Flint-Richter, Sigal Starinsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotyping of patients with sporadic and radiation-associated meningiomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-04-0366"}], "href": "https://doi.org/10.1158/1055-9965.EPI-04-0366"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15824172"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15824172"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Roberta Sestini, Costanza Bacci, Aldesia Provenzano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.20679"}], "href": "https://doi.org/10.1002/humu.20679"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18072270"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18072270"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "K D Hadfield, W G Newman, N L Bowers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2007.056499"}], "href": "https://doi.org/10.1136/jmg.2007.056499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18285426"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18285426"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "J Huang, J Chen "}, {"type": "b", "children": [{"type": "t", "text": "VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2008.44"}], "href": "https://doi.org/10.1038/onc.2008.44"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18332868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18332868"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ying-Ka Ingar Lau, Lucas B Murray, Sean S Houshmandi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Merlin is a potent inhibitor of glioma growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-0190"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-0190"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18632626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18632626"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Claudio Thurneysen, Isabelle Opitz, Stefanie Kurtz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional inactivation of NF2/merlin in human mesothelioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lung Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lungcan.2008.08.014"}], "href": "https://doi.org/10.1016/j.lungcan.2008.08.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18835652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18835652"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "D Lallemand, J Manent, A Couvelard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2008.427"}], "href": "https://doi.org/10.1038/onc.2008.427"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19029950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19029950"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "S K Selvanathan, A Shenton, R Ferner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Further genotype--phenotype correlations in neurofibromatosis 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0004.2009.01315.x"}], "href": "https://doi.org/10.1111/j.1399-0004.2009.01315.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19968670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19968670"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Gillian L Dalgliesh, Kyle Furge, Chris Greenman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature08672"}], "href": "https://doi.org/10.1038/nature08672"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20054297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20054297"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Stéphane Goutagny, Hong Wei Yang, Jessica Zucman-Rossi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-10-0891"}], "href": "https://doi.org/10.1158/1078-0432.CCR-10-0891"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20682713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20682713"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "I Christiaans, S B Kenter, H C Brink, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2010.082420"}], "href": "https://doi.org/10.1136/jmg.2010.082420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20930055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20930055"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Alan M Hebert, Brian DuBoff, Jessica B Casaletto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Merlin/ERM proteins establish cortical asymmetry and centrosome position."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.194027.112"}], "href": "https://doi.org/10.1101/gad.194027.112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23249734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23249734"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Guangwu Guo, Juliann Chmielecki, Chandra Goparaju, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-1008"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-1008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25488749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25488749"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Maria E R Garcia-Rendueles, Julio C Ricarte-Filho, Brian R Untch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-15-0330"}], "href": "https://doi.org/10.1158/2159-8290.CD-15-0330"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26359368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26359368"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Aatur D Singhi, Alyssa M Krasinskas, Haroon A Choudry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2015.121"}], "href": "https://doi.org/10.1038/modpathol.2015.121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26493618"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26493618"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Gabriel G Malouf, Siraj M Ali, Kai Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Urol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.eururo.2016.01.051"}], "href": "https://doi.org/10.1016/j.eururo.2016.01.051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26895810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26895810"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Jin Sun, Xinhua Tian, Junqing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-017-0567-4"}], "href": "https://doi.org/10.1186/s13046-017-0567-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28764788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28764788"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Sameer Agnihotri, Suganth Suppiah, Peter D Tonge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-00174-7"}], "href": "https://doi.org/10.1038/s41467-017-00174-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28775249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28775249"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Tatsuhiro Sato, Yoshitaka Sekido "}, {"type": "b", "children": [{"type": "t", "text": "NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms19040988"}], "href": "https://doi.org/10.3390/ijms19040988"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29587439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29587439"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Jiao Wu, Alexander M Minikes, Minghui Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-019-1426-6"}], "href": "https://doi.org/10.1038/s41586-019-1426-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31341276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31341276"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Fansen Meng, Zhengyang Yu, Dan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2021.07.040"}], "href": "https://doi.org/10.1016/j.molcel.2021.07.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34453890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34453890"}]}]}]}
Synonyms BANF, ACN, SCH
Proteins MERL_HUMAN
NCBI Gene ID 4771
API
Download Associations
Predicted Functions View NF2's ARCHS4 Predicted Functions.
Co-expressed Genes View NF2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View NF2's ARCHS4 Predicted Functions.

Functional Associations

NF2 has 11,549 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 139 datasets.

Click the + buttons to view associations for NF2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of NF2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NF2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of NF2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of NF2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of NF2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of NF2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of NF2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of NF2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of NF2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of NF2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with NF2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with NF2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with NF2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of NF2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of NF2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of NF2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with NF2 gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with NF2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing NF2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of NF2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing NF2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing NF2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing NF2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing NF2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with NF2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with NF2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of NF2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with NF2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with NF2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with NF2 gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of NF2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by NF2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving NF2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving NF2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with NF2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with NF2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with NF2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with NF2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at NF2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of NF2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of NF2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing NF2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with NF2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with NF2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of NF2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with NF2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing NF2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of NF2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of NF2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of NF2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of NF2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of NF2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of NF2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving NF2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving NF2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving NF2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing NF2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing NF2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing NF2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by NF2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by NF2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by NF2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of NF2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of NF2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of NF2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NF2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of NF2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with NF2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with NF2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with NF2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of NF2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of NF2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of NF2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of NF2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NF2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPM Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of NF2 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with NF2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for NF2 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with NF2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for NF2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of NF2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of NF2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of NF2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate NF2 protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways 2026 pathways involving NF2 protein from the KEGG Pathways 2026 dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate NF2 protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of NF2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of NF2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with NF2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of NF2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of NF2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of NF2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of NF2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing NF2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain NF2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by NF2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting NF2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of NF2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of NF2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by NF2 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for NF2 from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of NF2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of NF2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing NF2 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
OMIM Gene-Disease Associations phenotypes associated with NF2 gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for NF2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of NF2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of NF2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving NF2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving NF2 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with NF2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Phosphosite-Disease Associations diseases associated with NF2 protein from the curated PhosphoSitePlus Phosphosite-Disease Associations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate NF2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving NF2 protein from the PID Pathways dataset.
Reactome Pathways 2024 pathways involving NF2 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NF2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NF2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NF2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of NF2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of NF2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at NF2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of NF2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of NF2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with NF2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of NF2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs drug perturbations changing phosphorylation of NF2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands ligand (protein) perturbations changing phosphorylation of NF2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of NF2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of NF2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of NF2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of NF2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of NF2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of NF2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of NF2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of NF2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with NF2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with NF2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving NF2 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving NF2 protein from the WikiPathways Pathways 2024 dataset.